Clinical Trial Update: Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjuvant gemcitabine hydrochloride with oxaliplatin versus observation in biliary tract cancer after surgical resection; status shows…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: UNICANCER | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 3 | Status: COMPLETED